- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-2-1-1-6-6-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 12 residues within 4Å:- Chain C: A.290, I.291, H.292, F.294, I.298, I.302, V.340, L.343, A.344, V.347, A.348, M.351
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:F.294, C:F.294, C:I.298, C:I.302, C:V.340, C:L.343, C:A.344
- Hydrogen bonds: C:H.292
CLR.5: 11 residues within 4Å:- Chain C: Y.180, L.183, A.184, G.187, I.188, Y.190, L.322, R.323, I.324, V.373, L.377
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:Y.180, C:L.183, C:L.183, C:A.184, C:I.188, C:R.323, C:I.324, C:I.324, C:V.373, C:V.373, C:L.377
CLR.7: 10 residues within 4Å:- Chain G: I.92, I.96, V.99, M.100
- Chain I: W.492, F.495, W.496, I.661, M.664, F.665
11 PLIP interactions:7 interactions with chain I, 4 interactions with chain G- Hydrophobic interactions: I:W.492, I:W.496, I:W.496, I:I.661, I:M.664, I:F.665, I:F.665, G:I.92, G:I.96, G:I.96, G:V.99
CLR.11: 9 residues within 4Å:- Chain H: F.87, I.96
- Chain J: W.492, F.495, W.496, L.499, I.661, M.664, F.665
10 PLIP interactions:8 interactions with chain J, 2 interactions with chain H- Hydrophobic interactions: J:W.492, J:F.495, J:W.496, J:L.499, J:I.661, J:M.664, J:F.665, J:F.665, H:F.87, H:I.96
CLR.13: 9 residues within 4Å:- Chain K: F.87, I.95, V.99
- Chain M: W.492, F.495, W.496, I.661, M.664, F.665
7 PLIP interactions:5 interactions with chain M, 2 interactions with chain K- Hydrophobic interactions: M:W.492, M:F.495, M:W.496, M:I.661, M:F.665, K:F.87, K:I.95
CLR.17: 10 residues within 4Å:- Chain L: F.87, I.96, V.99
- Chain N: W.492, F.495, W.496, L.499, L.653, M.664, F.665
13 PLIP interactions:10 interactions with chain N, 3 interactions with chain L- Hydrophobic interactions: N:W.492, N:F.495, N:W.496, N:W.496, N:W.496, N:L.499, N:L.653, N:F.665, N:F.665, N:F.665, L:F.87, L:I.96, L:V.99
CLR.19: 13 residues within 4Å:- Chain P: F.87, I.95, I.96, V.99, M.100
- Chain R: W.492, F.495, W.496, L.499, L.653, I.661, M.664, F.665
11 PLIP interactions:4 interactions with chain P, 7 interactions with chain R- Hydrophobic interactions: P:F.87, P:I.95, P:I.96, P:V.99, R:W.492, R:F.495, R:W.496, R:L.499, R:L.653, R:F.665, R:F.665
CLR.20: 10 residues within 4Å:- Chain O: F.87, I.92, I.95, I.96
- Chain Q: W.492, F.495, W.496, I.661, M.664, F.665
14 PLIP interactions:5 interactions with chain O, 9 interactions with chain Q- Hydrophobic interactions: O:F.87, O:I.92, O:I.95, O:I.96, O:I.96, Q:W.492, Q:W.492, Q:W.492, Q:F.495, Q:W.496, Q:W.496, Q:I.661, Q:F.665, Q:F.665
- 1 x AJP: Digitonin(Non-covalent)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.8: 5 residues within 4Å:- Chain I: R.432, N.433, N.642, A.645
- Ligands: NAG.9
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:N.642
NAG.9: 1 residues within 4Å:- Ligands: NAG.8
No protein-ligand interaction detected (PLIP)NAG.14: 3 residues within 4Å:- Chain M: N.642, A.645
- Ligands: NAG.15
1 PLIP interactions:1 interactions with chain M- Hydrogen bonds: M:N.642
NAG.15: 1 residues within 4Å:- Ligands: NAG.14
No protein-ligand interaction detected (PLIP)NAG.21: 6 residues within 4Å:- Chain Q: R.432, N.433, N.642, A.645, R.656
- Ligands: NAG.22
2 PLIP interactions:2 interactions with chain Q- Hydrogen bonds: Q:N.642, Q:R.656
NAG.22: 1 residues within 4Å:- Ligands: NAG.21
No protein-ligand interaction detected (PLIP)- 6 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
PIO.10: 15 residues within 4Å:- Chain E: S.124, G.125, R.126
- Chain I: F.597, P.598, G.599, L.601, R.602, R.603
- Chain J: L.812, F.813, P.815, P.816, K.817, Y.818
14 PLIP interactions:3 interactions with chain E, 7 interactions with chain I, 4 interactions with chain J- Hydrogen bonds: E:G.125, E:R.126, E:R.126, I:F.597, I:G.599, J:Y.818
- Hydrophobic interactions: I:F.597, I:F.597, I:L.601, J:F.813
- Salt bridges: I:R.602, I:R.603, J:K.817, J:K.817
PIO.12: 12 residues within 4Å:- Chain I: L.812, F.813, K.814, P.815, P.816, K.817, Y.818
- Chain J: F.597, P.598, G.599, L.601, R.602
10 PLIP interactions:4 interactions with chain I, 6 interactions with chain J- Hydrophobic interactions: I:F.813, J:P.598, J:L.601
- Hydrogen bonds: I:Y.818, J:G.599, J:R.602
- Salt bridges: I:K.817, I:K.817, J:R.602, J:R.603
PIO.16: 10 residues within 4Å:- Chain M: F.813, K.814, P.815, P.816, K.817, Y.818
- Chain N: F.597, P.598, G.599, R.602
6 PLIP interactions:3 interactions with chain N, 3 interactions with chain M- Hydrogen bonds: N:G.599, N:R.602
- Salt bridges: N:R.602, M:K.817, M:K.817
- Hydrophobic interactions: M:F.813
PIO.18: 11 residues within 4Å:- Chain M: F.597, P.598, G.599, L.601, R.602
- Chain N: F.813, K.814, P.815, P.816, K.817, Y.818
11 PLIP interactions:8 interactions with chain M, 3 interactions with chain N- Hydrophobic interactions: M:F.597, M:P.598, M:L.601
- Hydrogen bonds: M:F.597, M:G.599, M:R.602, N:Y.818
- Salt bridges: M:R.602, M:R.603, N:K.817, N:K.817
PIO.23: 12 residues within 4Å:- Chain Q: F.597, P.598, G.599, L.601, R.602, R.603
- Chain R: F.813, K.814, P.815, P.816, K.817, Y.818
11 PLIP interactions:8 interactions with chain Q, 3 interactions with chain R- Hydrophobic interactions: Q:F.597, Q:F.597, Q:P.598, Q:L.601
- Hydrogen bonds: Q:G.599, Q:R.602, R:Y.818
- Salt bridges: Q:R.602, Q:R.603, R:K.817, R:K.817
PIO.24: 13 residues within 4Å:- Chain Q: L.812, F.813, K.814, P.815, P.816, K.817, Y.818
- Chain R: F.597, P.598, G.599, L.601, R.602, R.603
10 PLIP interactions:7 interactions with chain R, 3 interactions with chain Q- Hydrophobic interactions: R:F.597, R:L.601, Q:F.813
- Hydrogen bonds: R:F.597, R:G.599, R:R.602
- Salt bridges: R:R.602, R:R.603, Q:K.817, Q:K.817
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vallese, F. et al., Architecture of the human erythrocyte ankyrin-1 complex. Nat.Struct.Mol.Biol. (2022)
- Release Date
- 2022-07-20
- Peptides
- Ankyrin-1: A
Blood group Rh(CE) polypeptide: B
Ammonium transporter Rh type A: CD
Protein 4.2: E
Glycophorin-B: F
Glycophorin-A: GHKLOP
Band 3 anion transport protein: IJMNQR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
KC
LD
QE
XF
PG
RH
aK
SL
bO
TP
cI
VJ
eM
YN
fQ
ZR
g - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-2-1-1-6-6-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CLR: CHOLESTEROL(Non-covalent)
- 1 x AJP: Digitonin(Non-covalent)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- 6 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vallese, F. et al., Architecture of the human erythrocyte ankyrin-1 complex. Nat.Struct.Mol.Biol. (2022)
- Release Date
- 2022-07-20
- Peptides
- Ankyrin-1: A
Blood group Rh(CE) polypeptide: B
Ammonium transporter Rh type A: CD
Protein 4.2: E
Glycophorin-B: F
Glycophorin-A: GHKLOP
Band 3 anion transport protein: IJMNQR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
KC
LD
QE
XF
PG
RH
aK
SL
bO
TP
cI
VJ
eM
YN
fQ
ZR
g - Membrane
-
We predict this structure to be a membrane protein.